JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 16 No. 6 488-491
© 1975 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McDougall, I. R.
Right arrow Articles by Kriss, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McDougall, I. R.
Right arrow Articles by Kriss, J. P.

In vivo Distribution of Vesicles Loaded with Radiopharmaceuticals: A Study of Different Routes of Administration

I. Ross McDougall*, June K. Dunnick, Michael L. Goris and Joseph P. Kriss

Stanford University Medical Center, Stanford, California

Correspondence: For reprints contact: Joseph P. Kriss, Div. of Nuclear Medicine, Stanford University Medical Center, Stanford, Calif. 94305.

ABSTRACT

The in vivo distribution of vesicles containing radiopharmaceuticals in their cavities has been studied using three routes of administration: intravenous, subcutaneous, and intraperitoneal. The in vivo distribution in mice was determined by dissection of the animals and calculation of radioactivity in the organs. In rats the in vivo distribution was assessed by scintigraphy using a scintillation camera-digital computer unit. After intravenous injection of vesicles, radio-activity is concentrated to some extent in the liver and spleen but the pattern of distribution is different from that of the corresponding free radiopharmaceutical or radiocolloid made of the corresponding radionuclide. The permeability of the vesicular membrane to contained radiopharmaceutical has been shown to vary according to the chemical composition of the vesicles. Vesicles can be used to introduce materials in vivo and the potential exists for their specific targeting by coupling other molecules to their surfaces.

FOOTNOTES

* Commonwealth Fellow (1972–1974). Present address: Dept. of Medicine, University of Glasgow, Glasgow, Scotland.




This article has been cited by other articles:


Home page
ScienceHome page
M. Mauk, R. Gamble, and J. Baldeschwieler
Vesicle targeting: timed release and specificity for leukocytes in mice by subcutaneous injection
Science, January 18, 1980; 207(4428): 309 - 311.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1975 by the Society of Nuclear Medicine.